The KISS answer is that the "B16 as a Mouse Model for Human Melanoma"s is accepted as an excellent correlation and exactly what the FDA needs IMO to okay $ONCS proposed Melanoma Combo Phase2B.
not being a scientist or drug company employee with experience in reading or, more importantly understand what your reading i can say of being average inteligence that this is ''positive news'' and i further believe it will be well recieved tomorrow when the bell is rung in lower manhattan